Company Overview of Virionics Corporation
Virionics Corporation operates as a biotechnology company. The company offers development, marketing, and commercialization of antigen presentation platform for the prevention and treatment of infectious diseases, cancers, and inflammatory diseases in the United States. Its products include PapviRx, an human papillomavirus therapeutic vaccine for the treatment of cervical dysplasia, and metastatic cervical cancer in women; HepCVax, an hepatitis C virus vaccine (HCV) for the prevention of HCV infection, and treatment of chronic HCV diseases; and RetroVax human immunodeficiency virus (HIV) vaccine to prevent HIV infection. The company was founded in 2003 and is based in Scottsdale, Arizona.
8643 East Preserve Way
Scottsdale, AZ 85266-1320
Founded in 2003
Key Executives for Virionics Corporation
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Virionics Corporation, please visit www.virionics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.